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Previous studies have demonstrated chemo-preventive potential of cruciferous and 
apiaceous vegetables against colon cancer. Colon inflammation is one condition closely related 
with colon cancer initiation. Therefore, we wanted to compare if total western diet (TWD) was 
as pro-inflammatory as died-induced obesity (DIO) and a better dietary model for human 
conditions, and determine if diet supplementation with cruciferous (broccoli, watercress and 
cabbage) or apiaceous vegetables (celery and parsnip) could reduce dietary inflammation, and 
which vegetable was more effective.  
Male CBL57/6J mice were fed chow for seven days, on day eight, mice were assigned to 
one of the following diets: American Institute of Nutrition, 1993 diet for growth, pregnancy and 
lactation (AIN-93G), DIO, DIO+21% cruciferous (DC), DIO+21% apiaceous (DA), TWD, 
TWD+21% cruciferous (TC), and TWD+21% apiaceous (TA). On day 84 blood, colon, and liver 
were collected and stored at -80°C. Cytokine were measured in plasma (ARY006 array), and 
pro-inflammatory related genes were measured in colon tissue (PAMM-011Z array).  
The DIO group did not differ in weight gain compared to any other group. Some 
cytokines signals in DA were likely to be increased when compared to DIO (G-CSF, IL-5, IL-6 , 
IL-7, I-TAC, TNF-α, TREM-1; p < 0.005) and when compared to DC (G-CSF, IL-2, IL-5, IL-7, 
IL-23, IP-10, I-TAC, M-CSF, TARC, TIMP-1, TNF-α; p < 0.005). Bmp2 had a higher mRNA 
expression in all diets compared to basal diet AIN-93G; p= 0.001. Ccl1 had  similar mRNA 
expression in all diets compared to AIN-93G and DIO; p= 0.001. Ccl19 mRNA was equality 
expressed in all diets except for DIO; p= 0.000. Ccl4 had a higher mRNA expression in TC diet 
only when compare with DIO and DC; p= 0.058.  
DIO and TWD did not induce inflammation or obesity. Vegetable-supplemented diets 
induced secretion of some pro-inflammatory cytokines. Cruciferous had a smaller inflammatory 
response compared to apiaceous vegetables. Although no beneficial effect was seen of 
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Chapter 1: Introduction 
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide and the 
second leading cause of cancer death in the United States (Thélin & Sikka, 2015). Worldwide 
epidemiological studies have documented the highest rates of colorectal cancer in developed 
countries with western-style diets, which are diets high in fats, red meats, and refined grains 
while low in fiber and fruit consumption (Arnold et al., 2017; Boyle & Langman, 2000). 
Furthermore, several studies show that migrants and their children acquired the colorectal cancer 
risk of their host countries, demonstrating that colorectal cancer is associated with environmental 
factors, diet being part of that environment (Haggar & Boushey, 2009; Santarelli, Pierre, & 
Corpet, 2008). Even with advances in the treatment of colorectal cancer, the survival rates 
improve too slowly. Therefore, colorectal cancer prevention is a major goal for public health and 
the understanding of the mechanism of colorectal cancer prevention would improve prevention 
strategies (Santarelli et al., 2008).  
The effects of diet in the incidence of colorectal cancer is related to whether the diet is 
pro-inflammatory or anti-inflammatory. Several studies proposed possible pathways by which 
pro-inflammatory foods, such as high fat foods and red meat, may increase risk, these include the 
presence of heme iron and the production of carcinogens such as polycyclic aromatic 
hydrocarbons (Santarelli et al., 2008), but there are comparatively fewer studies about anti-
inflammatory foods and even fewer about possible mechanisms responsible for their anti-
inflammatory effects. One of these mechanisms include the suppression of  NF- κB, (which is a 
central mediator of inflammation)n by isothiocyanates present in cruciferous vegetables (Pahl, 
1999).  
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This type of vegetable has also been studied for its protective effects against colon cancer 
and some mechanisms include: the regulation of epigenetic and the metabolism xenobiotics, 
inhibition of cell proliferation and tumorigenesis, and their antioxidant activity (Pan et al., 2018). 
Apiaceous vegetables rich in furanocoumarins and polyacetylenes, is another group that has also 
shown chemo-preventing effects against colon cancer by the inhibition of cytochrome P450 
(Boyle & Langman, 2000; J. Kim, Gallaher, Chen, Yao, & Trudo, 2014; J. Kim et al., 2017; 
Peterson, Lampe, Bammler, Gross-Steinmeyer, & Eaton, 2006).  
It is important to mention that most studies have been carried out in animal models (rats, 
mice), testing individual compounds, but not the use of whole vegetables or a combination of 
different classes of vegetables as would be consumed in real life. In addition, these studies have 
used a high-fat diet (60% fat) as the background diet of their studies. However, intake of 60% of 
calories from fat is extreme and unlikely in real life settings. For these reasons, the aims of our 
study were: 
1) To compare the intestinal inflammatory response of two background diets, diet 
induced obesity (DIO) and total western diet (TWD) in C57BL/6J mice, and identify which one 
of these rodent diets would serve as a better dietary model of inflammation that reflects the 
human condition; 
2) To determine if supplementation with two classes of vegetables, cruciferous (broccoli, 
cabbage, and watercress) and apiaceous (celery, and parsnips), can reduce the inflammatory 
response to an inflammation-producing diet, and which class of vegetable is more effective. 
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We hypothesized that TWD would be as pro-inflammatory as DIO, and therefore a better 
dietary model of inflammation that reflects the human condition. Furthermore, we also expected 
that vegetable supplementation would reduce the inflammatory response produced by diet, 
through the modulation of keys signaling pathways such as: NF-κB, Wnt/β catenin, or MAPK. 
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 Chapter 2: Literature Review 
Colon Cancer Worldwide and in the United States of America 
Colorectal cancer continues to be the third most common cancer worldwide and the 
fourth most common cause of cancer death with nearly 1.4 million new cases and 700,000 deaths 
reported in 2012. It is predicted that the worldwide incidence of colorectal cancer will increase to 
2.4 million by 2035. About two thirds of colorectal cancer cases in 2012 occurred in countries 
with high or very high development indices (World Cancer Research Fund/American Institute 
for Cancer Research, 2017). 
In terms of geographical distribution, the Human Development Index (HDI) helps to 
compare the trends in incidence and mortality rates between developed and developing countries. 
There is an increasing incidence and mortality in countries with medium to high HDI, in 
particular Eastern Europe, Asia, and South America. Stabilizing or decreasing mortality trends 
are only observed in highly developed countries like USA, Australia, New Zealand, and several 
Western European countries. Females tend to have lower incidence rates than males, maintaining 
this pattern across the globe (Arnold et al., 2017).  
In the United States, colorectal cancer is the third most common cancer and the second 
leading cause of death. In 2018, it was estimated to have caused 140,250 new cases representing 
8.1% of all new cancer cases. From these, 97,220 cases corresponded to colon cancer and 43,030 
to rectal cancer. As for mortality colorectal cancer, it is estimated to cause 50,630 deaths 
representing 8.3% of all cancer deaths in 2018. Colorectal cancer is more common in men than 
women and among those of African American descent (Noone AM, 2018). 
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What is Colon Cancer? 
The National Cancer Institute Dictionary defines cancer as the term for diseases in which 
abnormal cells divide without control and can invade nearby tissues. These cells can also spread 
to other parts of the body through the blood and lymph systems. Colon cancer is a cancer that 
forms in the tissues of the colon. Rectal cancer and colon cancer are generally grouped together 
because of their many common features. In this case, the term colorectal cancer is used to refer 
to the cancer that starts in the colon or the rectum (American Cancer Society, 2017).  
Precursor lesions of colorectal carcinoma. 
There are many types of colorectal cancer, but around 96% of colorectal cancers are 
classified as adenocarcinomas. Some other less common types of colorectal cancer are: carcinoid 
tumors that start in hormone-making cells in the intestine; gastrointestinal stromal tumors that 
start in the interstitial cells of Cajal, and lymphomas that start in the lymph nodes, but can also 
start in the digestive system (for example, Non-Hodgkin Lymphoma). In addition, sarcomas, 
which are very rare, can be initiated in blood vessels, muscle, or connective tissues in the walls 
of the colon and the rectum (American Cancer Society, 2017). Since the majority of colorectal 
cancers are adenocarcinomas, we will focus on this type of cancer and its classification in this 
review.  
Adenocarcinomas. 
Adenocarcinomas start in the glandular epithelial tissues of the colon and the rectum. 
Polyps are the most common precursor lesion of this type of cancer. According to their shape, 
lesions can also be classified as (a) pedunculated, if it has a mushroom-like shape; (b) sessile, if 
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it is elevated but completely attached to the colon wall; (c) flat, if it is elevated less than half of 
the diameter of the lesion; and (d) depressed, if part of the lesion surface is below the level of the 
surrounding mucosa. Furthermore, precursor lesions can also include syndromes such as 
inflammatory bowel disease and hamartomatous polyposis syndromes. Colorectal epithelial 
polyps have a complex classification and are a broad group of dysplastic and nondysplastic 
neoplasms, many of which are widely recognized to confer risk of colorectal carcinoma.  
Nondysplastic serrated polyps. 
 This type of polyp is divided in two groups (a) sessile serrated polyps with proliferative 
abnormalities and (b) hyperplastic polyps without proliferative abnormalities (American Cancer 
Society, 2017). The latter are the most common type of polyps in the colorectum. They are pale, 
sessile polyps with smooth contours and may display a layer of mucus on the surface (Waye JD, 
1990). Occasionally, cells are multinucleated and likely to represent a degenerative phenomenon 
(Kambham, Troxell, & Longacre, 2005). Mutually exclusive KRAS and BRAF mutations (genes 
coding for proteins involved in cell signaling and that play an important role in the 
transformation of small to intermediate sized adenomas) are frequently present in hyperplastic 
polyps, therefore challenging the notion that they are nonneoplastic lesions and lack malignant 
potential. KRAS mutations are detected in up to 47% of hyperplastic polys while BRAF 
mutations are detected in 40% to 76% (O'Brien et al., 2006). The other type of nondysplastic 
polyps are sessile serrated polyps, which are more common among women, unlike hyperplastic 
polyps. Sessile serrated polyps are present in 2% to 9% of endoscopically rejected polyps and 
7% to 21% of all nondysplastic serrated polyps (Higuchi & Jass, 2004; Torlakovic, Skovlund, 
Snover, Torlakovic, & Nesland, 2003). The crypts of these polyps are dilated at their bases, 
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frequently with branching or budding above the muscularis mucosae (Torlakovic et al., 2003; 
Torlakovic & Snover, 1996).  
Conventional adenomas.  
This type of lesion is present in 40% to 60 % of removed colorectal polyps. The number 
and size of the polyps are associated with the risk of cancer development (Winawer SJ, 1993). 
Adenomas can be defined as red, multilobulated masses that are either plaque-like or 
pedunculated (O’brien et al., 2004).  
According to their morphological appearances, adenomas are classified into three 
categories: tubular, villous, and tubulovillous. Tubular adenomas have at least a 75% volume of 
tubular or branched crypts, while villous adenomas have at least a 75% volume of slender fronds 
of a neoplastic epithelium. Lastly, tubulovillous adenomas only have a 25% to 75% volume 
limited to villous polyps (Winawer SJ, 1993). By definition, all adenomas are considered 
dysplastic and, depending on some cytologic and architectural features, the degree of dysplasia is 
classified as low-grade dysplasia and high-grade dysplasia. 
In low-grade dysplasia, crypts that are prominent infoldings of the epithelium narrower at 
their bases compared to the surface have a variable size and are not oriented towards the 
muscularis mucosae. The nuclei of cells maintain their position at the base of the cell and nuclei 
are elongated with small nucleoli. Apoptotic cells are likely to be detected in the deep or 
superficial positions of the crypts. A rich neutrophils infiltrate may also be present. On the other 
hand, in high-grade dysplasia, crypts have a cribriform growth and irregular budding. The cells 
in this type of crypt are stratified, with prominent nucleoli, mitotic figures, and luminal necrosis 
(Fenoglio, Kaye, & Lane, 1973).  
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The majority of colorectal adenocarcinomas develop via the adenoma-carcinoma 
sequence. This is initiated by the adenomatous polyposis coli (APC) mutation, failing to 
participate in the complex that sequesters and facilitates -catenin cytoplasmic degradation. 
Then, APC--catenin/Wnt signaling allows cytoplasmic accumulation of -catenin, which is 
then translocated to the nucleus facilitating transcription of protooncogenes and driving cell 
proliferation. 80% of adenomas have an APC inactivating mutation, which nearly all show 
aberrant nuclear -catenin immunoexpression, indicating that abnormalities in the Wnt signaling 
pathway are universal in this type of lesion.  
Serrated adenomas.  
This type of polyp is uncommon, accounting for about 1% to 2% of endoscopically 
removed colorectal adenomas (Longacre & Fenoglio-Preiser, 1990).  Serrated adenomas have 
tubules and villous projections of the lamina propria that support crypts with convoluted 
architecture. Non-goblet epithelial cells are the most affected:  the nuclei are elongated or 
penicillate with small nucleoli and smooth contours (Yantiss, Oh, Chen, Redston, & Odze, 
2007). Abnormalities in the APC/β-catenin/Wnt signaling are found in 13% to 20% of serrated 
adenomas and up to 70% of serrated adenomas host KRAS- Mutations (O'Brien et al., 2006; 
Sawyer et al., 2002). 
Sessile serrated polyps with dysplasia.  
This type of lesion is rare, accounting for 1% of all endoscopically removed polyps, and 
is more frequent in women than men aged 50 or older. The pathological features are 
heterogeneous, representing an intermediate stage in the progression of sessile serrated polyps to 
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invasive carcinoma (via DNA methylation and MSI). KRAS mutations are identified in less than 
10% of mixed polyps, while BRAF mutations are identified in 40% to 89% (Chan, Zhao, Leung, 
& Yuen, 2003; Gala & Chung, 2011). 
Risk Factors of Colon Cancer 
Nonmodifiable risk factors.  
Family history. 
Roughly 10% of colorectal cancer cases are hereditary. They are caused by inherited gene 
mutations and can be grouped in two main categories: Hereditary Nonpolyposis Colorectal 
Cancer (HNPCC) and Familial Adenomatous Polyposis (FAP). HNPCC is caused by changes in 
DNA repair genes; for example, a mutation in one of the DNA repair enzyme genes like MLH1, 
MSH2, MLH3, MSH6, PMS1, or PMS2 (Kinzler & Vogelstein, 1996). The lifetime risk of 
colorectal cancer in people with HNPCC may be as high as 80%. A large portion of FAP is 
caused by a mutation in the APC gene (Feldman, Friedman, & Brandt, 2010). All individuals 
diagnosed with FAP will develop colon cancer if the colon has not been removed by the age of 
40. Having a first-degree relative affected by colorectal cancer is another factor that can increase 
by two- to three-fold the risk of sporadic cancer. This risk can be even higher if the relative was 
younger than 45 years old when diagnosed or if more than one first-degree relative was 
diagnosed. A family history of adenomatous polyps also increases the risk of colorectal cancer 
(American Cancer Society, 2017; Haggar & Boushey, 2009).  
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Personal history. 
Personal history plays an important role in colorectal cancer risk. Adenomatous polyps 
are precursor lesions of colorectal cancer and it has been reported that around 95% of sporadic 
colorectal cancer develops from these lesions (American Cancer Society, 2017). The risk of 
developing colorectal cancer is higher in individuals with a history of adenomatous polyps than 
in individuals with no personal history. Similarly, a personal history of inflammatory bowel 
disease represents a relative risk of colorectal cancer between 4- to 20-fold (Feldman et al., 2010; 
Haggar & Boushey, 2009).  
Age. 
The American Cancer Society recognizes an increase in the detection of colorectal cancer 
after the age of 40, which rapidly increases after the age of 50. Nonetheless, recent studies have 
reported an increasing incidence among younger people (O'Connell, Maggard, Livingston, & 
Cifford, 2004). 
Modifiable risk factors.  
Body weight and physical activity.  
Excess body weight and physical inactivity are two interrelated risk factors that are 
responsible for about one-fourth to a third of colorectal cancers (Haggar & Boushey, 2009). 
Obesity can be responsible for the lack of physical activity in daily routines in men and women 
(Campbell et al., 2007; De Jong et al., 2005). On the other hand, higher overall levels of physical 
activity are associated with a lower risk of colorectal cancer. The increase of circulating 
estrogens and decrease of insulin sensitivity are some biological correlations of obesity that are 
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believed to increase cancer risk, particularly associated with excess abdominal adiposity 
independent of overall body adiposity. The increased risk of colorectal cancer associated with 
body weight and physical activity may not only be due to an increased energy intake but may 
reflect differences in metabolic efficiency (De Jong et al., 2005).  
Alcohol. 
An increased risk of developing colorectal cancer may be associated with regular alcohol 
consumption (Zisman, Nickolov, Brand, Gorchow, & Roy, 2006). Some of the mechanisms 
associated with alcohol consumption and cancer are: the production of acetaldehyde, as the first 
metabolite of ethanol oxidation (which can function as a carcinogen), the induction of 
cytochrome P-450E1 that leads to the generation of reactive oxygen species, and promotes the 
activation of various procarcinogens. Alcohol may also function as a solvent and enhance 
penetration of other carcinogens. In the presence of alcohol, some DNA mutations caused by 
smoking are less efficiently repaired (Pöschl & Seitz, 2004). Moreover, a diet low in essential 
nutrients is common in high alcohol consumers which can make tissues susceptible to 
carcinogenesis (Marmot et al., 2007). 
Cigarette smoking.  
Smoking is responsible for about 12% of colorectal cancer deaths (Zisman et al., 2006). 
Evidence has shown that smoking is an important factor in the formation and growth rate of 
adenomatous polyps which are documented precursor lesions of colorectal cancer (Botteri, 
Iodice, Raimondi, Maisonneuve, & Lowenfels, 2008). Long-term smoking has also been 
associated with larger polyps found in the colon and rectum (Tsong et al., 2007; Zisman et al., 
2006). Alkaloids, phenolic compounds, volatile aldehydes, polycyclic aromatic hydrocarbons, 
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tobacco specific nitrosamines and heavy metals, are classes of cigarette compounds that are 
known to induce free radicals and possess toxic and carcinogenic activities (Zhang et al., 2012). 
These compounds could induce tumorigenesis and promote cancer development in various 
sections of the gastrointestinal tract through different mechanisms including, activation of 
nicotinic acetylcholine receptors, the formation of DNA adducts, the stimulation of tumor 
angiogenesis, and modulation of immune response (Li et al., 2014).  
Environmental risk factors.  
Cultural, social, and lifestyle factors are among the broadly defined “environmental 
factors.” Migration and urban residence have been reported to increase the risk of colorectal 
cancer. For example, the offspring of Japanese migrants to the United States have a three to four 
times higher incidence of colorectal cancer than the Japanese living in Japan (Boyle & Langman, 
2000). Diets are part of the environmental factor, and the main focus of our research. 
Diet. 
Some diets are associated with a higher incidence of colorectal cancer. These diets 
include a high consumption of red or processed meat, a high consumption of fat, and a low 
consumption of calcium, fiber, fruit, and vegetables (Haggar & Boushey, 2009). The positive 
association of meat consumption is stronger for colon cancer than rectal cancer (Larsson & 
Wolk, 2006). Animal fat is the main fat source associated with colorectal cancer, while fiber 
intake may be responsible for the geographical differences in colorectal cancer rates observed 
between Africa and Westernized countries (World Cance Research Fund International; Fund & 
Research, 2007; Haggar & Boushey, 2009; 2017; Larsson & Wolk, 2006).  
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Inflammation and Colon Cancer 
Inflammation is a mechanism of the immune system as the first response to infection. In 
the context of tissue injury, inflammation could be defined as: “a multifactorial network of 
chemical signals to initiate and maintain a host response designed to heal the afflicted tissue.” 
The main components of inflammation are cells (neutrophils, eosinophils, monocytes, 
macrophages) and chemokines (Coussens & Werb, 2002).  
Role of inflammation in colon cancer risk. 
The relationship between inflammation and cancer is well accepted. This relationship has 
been studied for centuries. One can refer to Virchow in 1863, who associated inflammation with 
cancer (Fran Balkwill & Mantovani, 2001). In his hypothesis, he defined cancer as solely cell 
proliferation, caused by some irritants, tissue injury, and the inflammatory response that 
accompanied the injury. With the evolution of genetic technologies, many cancer pathways have 
been discovered, demonstrating that cancer is not only a matter of cell proliferation but includes 
a series of factors such as growth factors, an environment rich in inflammatory cells, active 
stroma, and DNA- damage promoting agents (Coussens & Werb, 2002). 
The relationship between colon inflammation and the development of colorectal cancer 
has been studied in different types of colorectal cancer including sporadic and hereditary cancer.  
Colitis-Associated cancer (CAC) is a subtype of colorectal cancer that might be most relevant to 
this relationship and is associated with inflammatory bowel disease (IBD). Moreover, the 
molecular mechanism by which inflammation promotes cancer development can vary from CAC 
and other types of colorectal cancer. This mechanism can also vary depending on which step of 
colon tumorigenesis inflammation is taking place, and it can include tumor initiation, promotion, 
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progression, and metastasis (Terzić, Grivennikov, Karin, & Karin, 2010). Furthermore, chronic 
inflammation is responsible for oxidative damages to DNA, which lead to p53 mutations in 
inflamed epithelium and in tumor cells (Kraus & Arber, 2009). The mutations induced by 
inflammation can be a result of the direct oxidation of reactive oxygen species and the 
inactivation of mismatch repair enzymes at protein level (Colotta, Allavena, Sica, Garlanda, & 
Mantovani, 2009; Hussain, Hofseth, & Harris, 2003). Additionally, mouse and human studies 
have shown that DNA methyl transferases (Dnmt) 1 and 3 can be induced during inflammation 
silencing several target genes in colon cancer, but the inactivation of Dnmt resulted in the 
decrease of progression and suppression of tumor formation (Colotta et al., 2009; Hahn et al., 
2008). 
The immune system in colon cancer.  
Both CRC and CAC tumors are formed by different types of immune cells. Cells of the 
innate immune system that can be detected in these tumors include: neutrophils, mast cells, 
natural killer cells, dendritic cells (DCs) and tumor-associated macrophages (Atreya, Atreya, & 
Neurath, 2008). In advance tumors, a specific subset of cells can be detected, named myeloid-
derived suppressor cells, which help suppressing antitumor immune responses (Gabrilovich & 
Nagaraj, 2009). Cells from the adaptive immune system are also recruited and they may have 
pro- or anti-tumorigenic roles (Erdman et al., 2005).  
Cytokine Signaling and Tumor Promotion.  
The majority of tumor-promoting cytokines activate receptors on intestinal epithelial cells 
which activate oncogenic transcription factors and other oncogenic signaling pathways. Tumor 
Necrosis Factor (TNF), IL-6, and IL-1 are cytokines that promote colorectal cancer and CAC 
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tumor development. In contrast, IL-10 and TGF-β are cytokines that inhibit colorectal 
tumorigenesis (Christoph Becker et al., 2004; S. Wang, Liu, Wang, & Zhang, 2009). Frequently, 
in early states of CAC development tumor-promoting cytokines are produced by lamina propria 
macrophages and DC and by T cells in a late stage of progression (Christoph Becker et al., 2004; 
Grivennikov et al., 2009).  
The activated protease ADAM17 mediates shedding of the membrane-bound IL-6 
receptor. IL-6 receptor in its soluble form activates transcription factor STAT3 via trans-
signaling. IL-6 stimulates proliferation of premalignant enterocytes and tumor growth (C Becker 
et al., 2005; Christoph Becker et al., 2004). STAT3 can also be activated by different cytokines 
(IL-11, IL-22), growth factors (hepatocyte growth factor), epithelial growth factor receptor 
ligands (TGF-α, EGF), and oncogenic tyrosine kinases (c-Met, Src) (Pickert et al., 2009). Once 
activated, STAT3 protects the gastrointestinal epithelium and stimulates its regeneration, 
promoting proliferation of pre-malignant cells (Grivennikov et al., 2009). The activation of 
STAT3 produces the expression of Bcl2 or Bcl-xL (which are antiapoptotic genes), Cyclin D1 or 
c-Myc (which are proliferative genes), and vascular endothelial growth factor (VEGF) (Naugler 
& Karin, 2008a). The activation of STAT3 also induces prolonged activation of the transcription 
factor NF-κB and both transcription factors activate genes required for every aspect of cancer 
development (Lee et al., 2009). IL-6 promotes Th17 cell differentiation and regulates the 
survival of proinflammatory Th1 cells while inhibiting T regulatory (Treg) cells (Bettelli et al., 
2006; Dominitzki et al., 2007).  
TNF is produced during initial inflammatory response. Some of its properties include 
production of other cytokines, chemokines and endothelial adhesion molecules, increase of 
vascular permeability, and recruitment of activated leukocytes. As a result, TNF can be 
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considered a tumor-promoting factor because it promotes inflammation angiogenesis and tumor 
dissemination (Frances Balkwill, 2009). TNF also activates transcription factors AP-1 and NF-
κB (Frances Balkwill, 2009; Kruglov et al., 2008). Moreover, TNF is the main factor responsible 
for inactivation of transcription factor T-bet in DCs that led to spontaneous intestinal 
inflammation and CAC (Garrett et al., 2009).  
Cytokines, that are upregulated in various types of cancers include IL-1 and IL-23. The 
mechanisms of action of IL-23 in CRC and CAC are not clear but it could be due to the effect of 
IL-23 on differentiation and propagation of Th17 cells or its effects in monocytes, memory T 
cells, and Tregs (Garlanda et al., 2007; Wirtz & Neurath, 2007).  
TGF-β has a contradictory role in cancer development. It displays an antitumorigenic role 
by inhibiting proliferation, stimulating apoptosis, and by suppressing pro-tumorigenic cytokine 
expression (LI Yang & Moses, 2008). However, during malignant progression, TGF-β promotes 
epithelial-mesenchymal transition and suppresses the antitumor activity of immune cells to 
facilitate metastasis (Bierie & Moses, 2010; Linda Yang, Belaguli, & Berger, 2009). 
Proposed Inflammatory pathways. 
NF-κB pathway 
NF-κB transcription factors are dimers assembled through five subunits: p105/p50, 
p100/p52, RelA (p65), c-Rel, and RelB. Active NF-κB signaling in premalignant and 
inflammatory cells are responsible for the activation of the majority of tumor-promoting 
cytokines (Karin, 2006). NF-κB activation can increase cell proliferation and angiogenesis, 
inhibit cell death, and promote cell invasion and metastasis, all of which supports tumorigenesis 
(Naugler & Karin, 2008b). Furthermore, the five subunits of NF-κB can be held inactive as 
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precursors in the cytoplasm or by the inhibitor of κB, Ikb protein. A simple explanation of the 
activation of NF-κB via the classical route would be: 1) pattern recognition receptors, TNF, IL1, 
and IL17 are the initial signal transduction pathways; 2) The initial signals activate the IKB 
kinase (IKK) complex (mostly IKK GAMMA and BETA), which phosphorylates the IKBs; 3) 
IKBs are targeted for ubiquitination and ultimate degradation in proteasome; and 4) after IKBs 
degradation, NF-κB is liberated, mainly p50/p65, to migrate to nucleus and regulate gene 
transcription (Vallabhapurapu & Karin, 2009). Another route to activate NF-κB is activation by 
cytokines such as RANKL and lymphotoxin-B that would activate IKK alpha homodimer which 
liberates mainly p52/ReIB NF-κB (Karin, 2006). In mouse studies, conditional ablation of IKKB 
in enterocytes decreased tumor formation by 80% but did not affect tumor size, suggesting that 
the activation of NF-κB is part of an early stage of tumor promotion rather than progression or 
growth (Greten et al., 2004). 
Wnt/β-catenin pathway 
The Wnt/β catenin pathway plays a central role in the development of colorectal cancer. 
Several molecules are involved in the positive or negative regulation of this pathway, with β-
catenin being the most important and critical molecule among these.  
In unstimulated cells free cytoplasmatic β-catenin is destabilized by a multiprotein 
complex formed by Axin, glycogen synthase kinase 3β (GSK3) and APC (a tumor suppressor). 
Interaction between Axin and GSK3 facilitates efficient phosphorylation of β-catenin by GSK3 
and this phosphorylation event marks β-catenin for ubiquitination and ultimate destruction. On 
the other hand, the cytoplasmatic protein Dishevelled (Dsh) is recruited to the membrane when 
cells are stimulated by Wnt ligands. Dsh binds to Wnt through Frizzled (a transmembrane 
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receptor for the Wnt ligands), the Wnt signaling prompts the inhibition of the destabilization of 
free cytoplasmic β-catenin by the Axin complex. Now the stabilized β-catenin is release from the 
Axin complex and is translocated into the nucleus where it binds to T cell factor (TCF) to 
stimulate the transcription of Wnt target genes (Bienz & Clevers, 2000).  
Additionally, APC is a protein normally expressed in nonproliferating colorectal 
epithelium and is essential for the control of normal growth and cell differentiation 
(MPOCC,2013). About 85% of all sporadic and hereditary colorectal tumors show loss of APC 
function. Colon cancer cells with mutant APC contain high levels of free β-catenin which can be 
down regulated by exogenous wild type APC. The anti-tumorigenic effects of APC are not only 
limited to β-catenin degradation but also to the suppression of Wnt pathway by acting on 
promoter of Wnt responsive genes and the shuttling of β-catenin out of the nucleus (MPOCC, 
2013).  
MAPK pathway 
The mitogen activated protein kinase (MAPK) pathway is part of the family of serine-
threonine kinases and it has three major subfamilies for MAPK: the extracellular signal-regulated 
kinases (ERK MAPK, Ras/ Raf1/ MEK/ ERK), and the c-Jun N-terminal or stress-activated 
protein kinase (JNK or SAPK; and MAPK14). It is well established that in humans beings these 
three subfamilies can alter gene expression (Hommes, Peppelenbosch, & Van Deventer, 2003), 
but ERK MAPK is the most relevant subfamily, as there is evidence that this pathway is 
involved in the pathogenesis, progression, and oncogenic behavior of human colorectal cancer 
(X. Wang, Wang, Hu, & Evers, 2004). In general, protein kinase C (PKC) activity promotes the 
binding of GTP to the RAS family, which leads to Raf1 activation and subsequent MAPK 
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activation. Furthermore, there is plenty of evidence that the inhibition of this pathway can 
prevent tumor growth and therefore the pathway is potentially useful as targets for treatment of 
colorectal cancer (Fang & Richardson, 2005; Sebolt-Leopold et al., 1999).  
Diet and Colon Inflammation as a Risk of Colon Cancer 
Diet constituents that increase colon cancer risk 
Epidemiological studies have shown geographic variations in the incidence of colorectal 
cancer. The disease is most frequent in developed countries with a western culture, accounting 
for over 63% of all colorectal cancer cases (Haggar & Boushey, 2009). Among these studies, the 
“migrant studies” have significant importance because they provide direct evidence that suggests 
that environmental factors play a major part in the etiology of colorectal cancer. Around 70 to 
80% of colorectal cancers may owe their appearance to such factors (Boyle & Langman, 2000). 
In this type of study, populations migrating to a new and distant country and their offspring are 
monitored. The results indicate that the groups of migrants lose the risk associated with their 
country of origin to attain the patterns of their host country even after only one or two 
generations. The environmental factor related to colorectal cancer can be defined as the wide ill-
defined cultural, social and lifestyles practices or in a general sense to everything we get in touch 
with and we introduce into our organism (i.e., foods) (Boyle & Langman, 2000; Haggar & 
Boushey, 2009; Mutanen & Pajari, 2011).  
The influence of diet in colon cancer can go in two ways; diets that reduce the risk of 
developing colon cancer and diets that contribute to the risk of developing colon cancer. In 
respect to the diets that contribute to the risk of colon cancer a Western-style diet is positively 
associated with the development of colorectal cancer. This diet is characterized by being high in 
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meat, refined grains, and sugars while low in vegetables, and fiber (Slattery, 2000). Individual 
food parameters such as fat and red and processed meat have also been associated with the risk 
of colorectal cancer in ecological studies, animal experiments, and case-control and cohort 
studies (Boyle & Langman, 2000; Haggar & Boushey, 2009).  
The concept of a typical western diet is linked with the implication of fat, especially 
animal fat, as a possible etiologic factor for colorectal cancer. It is believed that fats will favor 
the development of bacterial flora capable of degrading bile salts to N-nitroso compounds that 
have a carcinogenic potential (Haggar & Boushey, 2009; Larsson & Wolk, 2006; Santarelli et al., 
2008). The examination of saturated fat was modestly associated with elevated C-reactive 
protein in 4,900 adult participants of the NHANES 99-00 (King, Egan, & Geesey, 2003). A 
study carried out in TLR4-deficient and wild type mice, compared a low fat diet (10 % kcal fat) 
to a high fat diet (60 % kcal fat) and found increased proinflammatory cytokines, increased 
plasma and fecal endotoxin levels, dysregulation of gut microbiota, and induced colitis in 
association with the high-fat diet (K.-A. Kim, Gu, Lee, Joh, & Kim, 2012).  
Many studies have demonstrated the positive association of high consumption of red and 
processed meat with the development of colorectal cancer. Santarelli et al, reviewed different 
types of studies (cohort, case-control, and meta-analysis) in animals and in humans to gather 
evidence and to explain possible mechanisms for the development of colorectal cancer. They 
hypothesized that the potential mechanisms of this association are: the presence of heme iron in 
red meat and the production of heterocyclic amines and polycyclic aromatic hydrocarbons from 
meats cooked at high temperatures. They also found that processed meat has an excess risk of 20 
to 50% in the highest category of processed meat-eaters compared to non-eaters. When 
comparing dose-response per gram of processed meat with grams of red meat in meta-analysis 
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studies, one gram of processed meat is at least twice and up to eleven times more promoting of 
colorectal cancer than red meat (Haggar & Boushey, 2009; Larsson & Wolk, 2006; Santarelli et 
al., 2008).  
Furthermore, these studies only reflect the effect of individual foods but not the effect of 
whole diets as would be consumed in everyday life. Therefore Shivappa et al. studied the 
association between the inflammatory potential of overall diet and mortality with a focus on 
cancer, specifically digestive-tract cancer mortality, including colorectal cancer. The diet 
inflammatory index (DII) was previously developed with various inflammatory markers 
including C-reactive protein, IL-1β, IL-4, IL-6, IL-10, and TNF-α. The study estimated that 
subjects in a higher DII tertile were a 110% more likely to die from digestive-tract cancer than 
those subjects in a lower DII tertile 1. It is also relevant that this study found an increased intake 
of red meat in the lowest DII which is opposite to what was expected, but as this study took into 
account diet as a whole, read meat eaters could have a lower DII if they ate sufficient amounts of 
other anti-inflammatory components such as (fibers, vegetables, fruits) (Shivappa, Steck, 
Hussey, Ma, & Hebert, 2017). 
Diet constituents that decrease colon cancer risk 
There is growing evidence that groups of vegetables, such as cruciferous and apiaceous, 
may be beneficial in the prevention of colorectal cancer. A meta-analysis study evaluated 24 
case-control studies and found an inverse association between high intake of cruciferous 
vegetables and colorectal cancer risk with similar results with cabbage and broccoli (Wu et al., 
2013). Furthermore, there is also evidence of decreased inflammatory cytokines levels associated 
with the consumption of cruciferous vegetables, for example: a multiethnic study found an 
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inverse relationship between a vegetable dietary pattern (cruciferous and apiaceous vegetables 
included) and the levels of CRP and IL-6 (Nettleton et al., 2006) Similarly, a randomized trial in 
healthy adults used cruciferous vegetables and a combination of cruciferous plus apiaceous 
vegetables, and concluded that both classes of vegetables were responsible for reduced levels of 
IL-6 (Navarro et al., 2014). Moreover, Chinese middle-aged women had levels of TNF, IL1β, 
and IL-6 inversely correlated with highest intake of cruciferous vegetables (Jiang et al., 2014).  
Therefore, in the present project, we hypothesize that TWD would be as pro-
inflammatory as DIO, and therefore a better dietary model of inflammation that reflects the 
human conditions. Furthermore, we also expect that vegetable supplementation will reduce the 
inflammatory response produced by diet, through the modulation of keys signaling pathways 
such as: NF-κB pathway, Wnt/β catenin, or the MAPK. 
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Chapter 3: Materials and Methods 
Animals and experimental design 
An animal use protocol was submitted and approved by the University of Arkansas 
Institutional Animal Care & Use Committee (IACUC) to purchase a total of 84 male C57BL/6J 
mice (~4 weeks old) from Jackson Laboratory (two sets of 42 mice two weeks apart from each 
other).  
Upon arrival, animals were housed at the Central Laboratory Animal Facility and adapted 
to a vegetable free-chow diet for 1 week. On day 8 mice were randomly assigned to one of the 7 
different diets (n=6) for a total of 12 weeks. Mice were housed in the following conditions: 7 
cages of 16.75” x 10.5” x 6”, 6 mice per cage, temperature of 22±0.5ºC, 50% humidity, 12 hour 
light/dark cycle, free access to water and diets, and bedding and water refreshment every 3 days. 
Body weight and 24-hour food intake was measured once a week. The second set of mice was 
handled with the same protocol. During the study, four mice from the TWD group were 
euthanized; three due to skin problems related to one aggressive mouse in the cage and one with 
a broken leg.  
At the end of their assigned diet intervention, mice were euthanized with CO2 and by 
cardiac puncture. Blood samples were collected with EDTA anticoagulant, livers were split in 
two (one half preserved in liquid nitrogen and the other half in RNAlater solution), and colons 
were washed with PBS and stored in RNAlater solution (life technologies, Carlsbad, CA). 
Tissues stored in RNAlater solution were left overnight at 4 C and moved to -80 C after 24 
hours.  
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Study diets  
Seven different types of diets were prepared for this study: AIN-93G (American Institute 
of Nutrition, 1993 diet for growth, pregnancy and lactation) was used as control diet, DIO (diet-
induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet 
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western 
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous 
vegetables). All diet ingredients were purchased from Dyets.inc (Bethlehem, PA). Powdered 
ingredients were stored at -20C, while liquid ingredients were stored at 4C until needed.  The 
formulation of AIN-93G was based on Reeves, Nielsen, and Fahey’s work (1993). The DIO was 
formulated to be a high fat diet (60% calories from fat) and TWD was also formulated based on a 
previous work (Hintze, Benninghoff, & Ward, 2012). Cruciferous vegetable-supplemented diets 
contained fresh watercress, broccoli, and green cabbage (21%, wet wt:wt; 7% per each 
vegetable). Apiaceous vegetable-supplemented diets included fresh celery and parsnip (21%, wet 
wt:wt; 10.5% per each vegetable). Furthermore, all vegetable supplemented diets were balanced 
for macronutrients and dry weights for each vegetable was taken from the United States 
Department of Agricultural nutrient database and summed according to each diet. Composition 
of the study diets are summarized in Table 1.  
Organically grown vegetables were purchased in three batches from two local markets: 
broccoli, green cabbage, celery and parsnip at Ozark Natural Foods (Fayetteville, AR) and 
watercress at Whole Foods (Fayetteville, AR). Diets were prepared the same day of purchase. 
Vegetables were washed, dried with paper towels and peeled if necessary (parsnip), chopped into 
small pieces, and ground in a food processor (Cuisinart Deluxe, NJ) to further be mix with either 
DIO or TWD respectively using a mechanical mixer (Hobart, A-200-D) for 15 minutes.  
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Each diet was aliquoted in freezer bags (1 bag = 1 week of feeding) and stored at -80C 
until fed. Aliquots were thawed at room temperature and fed to animals every three to four days.  
Plasma cytokine expression assay 
After collection, blood samples were kept on ice, and centrifuged at 11,180g for 15 
minutes at 4°C, supernatant (plasma) was collected and stored at -80°C on the same day of 
sample collection. Before conducting the cytokine array, we determined the total protein 
concentration using the 23227 PierceTM BCA protein assay kit from Thermo Fisher Scientific 
(Waltham, MA), and we diluted the samples to the lowest protein concentration to perform the 
array.  
The ARY006 mouse cytokine array panel A (R&D Systems, Minneapolis, MN) was used 
to assess systemic effects of the dietary intervention on plasma cytokine expression. In brief, 
samples from two mice were pooled to obtain three pooled samples per diet group. Three 
replicas were performed, each containing one pooled sample per diet group. Nitrocellulose 
membranes with 40 selected capture antibodies spotted in duplicate were blocked with 2 mL of 
array buffer six for one hour on a rocking platform shaker. 100 µl of pooled plasma samples 
were mixed with 500 µl of buffer four, 900 µl of buffer six and 15 µl of biotinylated detection 
antibodies and incubated at room temperature for one hour. Buffer six was aspirated from 
membranes and samples mixture was added to membranes for overnight incubation at 2-8 °C on 
a rocking platform shaker. On the next day membranes were removed from the mixture and 
washed twice with 20 ml of wash buffer for ten minutes on a rocking platform shaker. After 
wash, the excess buffer was drained with paper towels and membranes were incubated 30 
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minutes with 2 mL of streptavidin-horse radish peroxidase at room temperature on a rocking 
platform shaker.  
The washing procedure was repeated and the next steps were performed in a dark room: 
membranes were placed in a plastic sheet protector and one mL of chemiluminescent reagent 
mix was added to the membranes and incubated for one minute, the excess reagent was removed 
with absorbent lab wipes and membranes were place in an autoradiography film cassette. 
Membranes were exposed in duplicate to X-ray film for five and ten minutes. The light produced 
at each spot was proportioned to the amount of cytokine bound.  
The signal intensity of the blot membranes was measured using the recommended 
manufacturer software HLImage++ (Western Vision Software, Salt Lake City, UT). 
Measurements were normalized with negative control spots and AIN-93G control diet.  
Colon cytokine expression array 
Moreover, we explored which inflammation-related genes may be differentially 
expressed by the experimental diets, we used the PAMM-011Z Inflammatory Cytokines and 
Receptors RT2 Profiler PCR Array (Qiagen, Hilden, Germany). In brief, RNA from colon tissue 
was extracted and purified using the 73404 RNeasy Plus Universal Kit (Qiagen, Hilden, 
Germany). Quality of isolated RNA was  monitored with the measured A260/280 ratio and RNA 
Integrity Numbers (Agilent 2100 Bioanalyzer, Santa Clara, CA). The assay was carried out in 
pooled RNA samples of equal amounts from two mice for a total of six mice and three samples 
per diet group: in brief, extracted RNA was reverse transcripted to cDNA following the 
manufactures instruction on the PCR array using the ABI StepOnePlus real time-PCR system 
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(Applied Biosystems, Waltham, MA). Data was normalized to housekeeping genes and analyzed 
based on ΔΔCT method.  
Statistical analysis 
The software SPSS 19.0 was used to perform data analyses. One-way analysis of 
variance (ANOVA) was used to determine statistical differences between basal diets (DIO diet 
vs TWD diet) and the effect of added vegetables (no vegetables vs vegetable added diets) for 
inflammatory responses. Individual group differences were inspected by Tukey test with a cut-
off p-value of 0.05.  
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Table 1. Composition of basal diets (AIN-93G, DIO, TWD) and vegetable supplemented 
diets 
*AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO 
(diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet 
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western 
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous vegetables). 
aAIN-93G mineral mix, purchased from dyets.inc catalog #210025.bCustom TWD mineral mix, 
purchased from dyets.inc catalog #210107. cAIN-93G vitamin mix purchased from dyets.inc 
catalog #310025. dCustom TWD vitamin mix, purchased from dyets.inc catalog #310088. eCustom 
fat blend for the University of Minnesota, purchased from dyets.in catalog #103860. fWatercress 
(70g), broccoli (70g), and green cabbage (70g), macronutrients peer group: carbohydrate 9.61g, 




DIO* D+C* D+A* TWD* T+C* T+A* 
Cornstarch  397.5 --- --- --- 230 220.4 207.99 
Casein 200 258.46 253.96 256.48 190 185.5 188 
Dextrinized 
cornstarch 
132 161.54 151.93 139.53 70 70 70 
Sucrose 100 88.91 88.91 88.91 261.4 261.4 261.4 
Fiber (cellulose 
bw200) 
50 64.62 60.72 57.79 30 26.1 23.17 
Potassium citrate H2O --- 21.32 21.32 21.32 --- --- --- 
Dicalcium phosphate --- 16.80 16.80 16.80 --- --- --- 
Calcium carbonate --- 7.11 7.11 7.11 --- --- --- 
L-cystine 3 3.88 3.88 3.88 2.85 2.85 2.85 
Sodium chloride --- --- --- --- 4 4 4 
Choline bitartrate 2.5 2.58 2.58 2.58 1.4 1.4 1.4 
Mineral mix ain-93ga 35 12.92 12.92 12.92 --- --- --- 
Mineral mix custom 
twdb  
--- --- --- --- 35 35 35 
Vitamin mix ain-93gc  10 12.92 12.92 12.92 --- --- --- 
Vitamin mix custom 
twdd  
--- 0.00 0.00 0.00 10 10 10 
Lard --- 316.62 316.22 316.123 --- --- --- 
Custom Fat blende  --- --- --- --- 165.35 165 164.856 
Soybean oil  70 32.31 32.31 32.31 --- --- --- 
tBHQ --- 0.01 0.01 0.01 --- --- --- 
Cruciferous 
vegetablesf 
  210 ---  210 --- 
Apiaceous 
vegetablesg  
  --- 210  --- 210 
Total (g) 1000 1000.00 1210.00 1210.00 1000 1210 1209.985 
Carbohydrate (%) h 62.95 25.05 24.64 24.40 56.14 55.24 54.70 
Protein (%) h 20.00 25.85 25.43 25.18 19.00 18.69 18.51 
Fat (%) h 7.00 34.89 34.33 34.00 16.54 16.27 16.11 
Dietary fiber (%) h 5.00 6.46 6.36 6.30 3.00 2.95 2.92 
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carbohydrate 22.01g, protein q1.98g, fat 0.50g, fiber 6.80g. hPercent of macronutrient after 
removing water weight of vegetables: 193.62g from cruciferous and 183.71g from apiaceous. 
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Chapter 4: Results  
Food intake  
There were no differences in food intake between groups on week one of the study. On 
week 6, mice in TWD (14.99 kcal ± 0.21), TC ( 14.22 kcal ± 0.52) and TA (14.35 kcal ± 0.65) 
had decreased food intake compared to AIN-93G (20.17 kcal ± 2.88). At the end of the study 
(week 12) mice in DIO group (26.79 kcal ± 5.15) had increased food intake compared to all 
other groups except DC group. 
Body and Tissue weight  
Initial body weight of animals was between 21.64g to 28.56g. There were some 
unexpected differences in weight gain between some diet groups. The DIO group did not differ 
in weight gain compared to any other group (Figure 2). Weight gain of mice in DC (19.44g ± 
1.62) group was higher than the weight gained by mice on TWD (11.17g ± 1.75) and AIN-93G 
diet (11.41g ± 0.60), the latter having the lowest mean value. There were no differences in colon 
and liver weight between diet groups (Table 2).  
Plasma cytokine expression assay 
The mouse cytokine array panel A is able to detect 40 types of cytokines. This is a 
screening assay, therefore results are relative and not finite. In our study 18 cytokines (G-CSF, I-
309, IL-2, IL-5, IL-6, IL-7, IL-17, IL-23, IP-10, I-TAC, KC, M-CSF, MIP-2, SDF-1, TARC, 
TIMP-1, TNF-α, and TREM-1) were differentially expressed between diet groups (Figure 3). 
Mice in AIN-93G, DIO, and TWD had similar cytokine secretion profile with the lowest means 
compared to the vegetable-supplemented diets. KC was the only cytokine that increased in DIO 
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compared with TWD (p = 0.036). Cytokine signals in DC had the same secretion profile as 
cytokines in DIO with lower means but no statistical difference, while some cytokine signals in 
DA were likely to be increased when compared to DIO (G-CSF, IL-5, IL-6 , IL-7, I-TAC, TNF-
α, TREM-1; p < 0.015) and when compared to DC (G-CSF, IL-2, IL-5, IL-7, IL-23, IP-10, I-
TAC, M-CSF, TARC, TIMP-1, TNF-α; p < 0.026). Most cytokines in TC and TA had similar 
secretion profiles as TWD with slightly higher means, and with only three cytokines (G-CSF, I-
309 and M-CSF; p < 0.005) in TA with increased secretion compared to TWD. Cytokine 
secretion of IL-17 was increased on TC compared to DC; p = 0.042. MIP-2 expression was 
higher on TWD compared to AIN-93G and DC; p = 0.019, while SDF-1 was decreased on all 
diets compared to AIN-93G diet; p = 0.00.  
Colon cytokine expression array 
Only four inflammation-related genes were statistically different between diets. Bmp2 
had a higher mRNA expression in all diets compared to basal diet AIN-93G (p= 0.001). Ccl1 had 
similar mRNA expression in all diets compared to AIN-93G and DIO which had the lowest (p= 
0.001). Ccl19 mRNA was equally expressed in all diets except for DIO which had a lower 
expression (p< 0.001). Ccl4 had a higher mRNA expression in TC diet only when compared with 
DIO and DC (p= 0.058).  
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Table 2. Weight of colon and liver tissues collected from C57BL/J6 mice by diet group.  
Diet* Colon (g) Liver (g) 
AIN-93G 15.87 ± 1.02 169.91 ± 8.05 
DIO 16.64 ± 0.88 172.46 ± 8.71 
DC 17.13 ± 1.28 214.39 ± 29.54 
DA 15.75 ± 0.94 182.07 ± 17.32 
TWD 15.60 ± 0.93 164.68 ± 20.40 
TC 13.32 ± 0.46 160.92 ± 6.61 
TA 13.53 ± 1.17 170.43 ± 17.51 
*AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO 
(diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet 
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western 
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous 






Figure 1. 24-hour food intake of C57BL/J6 mice by week. Food cups were weighed on day of 
feeding (0 hour) and again 24 hours later. Cup weight at 0 hours was subtracted from cup weight 
at 24 hours and then divided by total animals on respective diets. This was measured once a 
week. AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), 
DIO (diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A 
(diet induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total 
western diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous 
vegetables). Values are reported as least squares means ± SEM, n=6 per diet group. Values 
within time points that do not share the same lowercase letters are different from each other 





Figure 2. Weight gain of C57BL/J6 mice by diet group. Weight gain was monitored once a 
week. Initial weight (day 0) was subtracted from final weight (day 85). AIN-93G (American 
Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO (diet-induced obesity), 
D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet induced obesity plus 
21% apiaceous vegetables), TWD (total western diet), T+C (total western diet plus 21% 
cruciferous vegetables), and T+A (total western diet and 21% apiaceous vegetables).Values are 
reported as least squares means ± SEM, n=6 per diet group. Bars that do not share the same 



























Figure 3. Effects of seven different diets on plasma cytokine secretion in C57BL/6J mice. 
AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO 
(diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet 
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western 
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous 
vegetables). The relative level of each cytokine or chemokine was calculated using HLImage++ 
software (Western Vision Software, Salt Lake City, UT). Values are reported as least squares 
means ± SEM, n=4 per diet group. Bars that do not share the same lowercases letters are 


















































































































































































































































































































Figure 4. Effects of seven different diets on mRNA expression of inflammation-relate genes 
in C57BL/6J mice. AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy 
and lactation), DIO (diet induced obesity), D+C (diet induced obesity plus 21% cruciferous 
vegetables), D+A (diet induced obesity plus 21% apiaceous vegetables), TWD (total western 
diet), T+C (total western diet plus 21% cruciferous vegetables), and T+A (total western diet and 
21% apiaceous vegetables). mRNA from colon tissue was extracted, purified and reverse 
transcripted to cDNA following manufactures instruction, real time PCR was run with the RT2 
profiler PCR array, data was normalized to housekeeping genes and analyzed based on ΔΔCT 
method. Values are reported as least squares means ± SEM, n=6 per diet group. Bars that do not 

























































































Chapter 5: Discussion and Future Directions 
Mice are one of the most useful models to study human diseases. Researchers are always 
trying to mimic human conditions; in this manner, the AIN-93G diet has widely been used to 
replicate an ideal human diet in mice models, and DIO to reproduce obesity, but none of these 
diets represent the larger group of Americans with an average diet. In an effort to replicate the 
average American diet, scientists developed the TWD as a background diet for rodent studies. 
TWD has not been compared to DIO regarding effects on colon inflammation. This is why in our 
study we wanted to compare these two diets in order to determine whether TWD is as pro-
inflammatory as DIO and a better model for human diseases, especially colon cancer, as it is a 
model more translatable to human conditions. Moreover, previous studies have demonstrated the 
chemo-preventive potential of cruciferous and apiaceous vegetables in the prevention of colon 
cancer (Koushik et al., 2007; Tse & Eslick, 2014; Wu et al., 2013), and colon inflammation is 
one of the conditions closely related with colon cancer initiation. Therefore, we also wanted to 
investigate the effect of these two classes of vegetables on colon inflammation. In the following 
pages, we discuss our findings, the strengths and limitations of our study, and what would be the 
further direction of our research. 
In our study, the similar plasma cytokine secretion profile found in AIN-93G compared 
to DIO, and TWD, differs from the study of Kyung-Ah Kim et al., where a high-fat diet (60% 
kcal % fat) produced higher levels of proinflammatory cytokines (TNF-α, IL-1β, and IL-6) 
compared to a low-fat diet (10% kcal % fat) (2012), using the same animal model C57BL/6J as 
our study.  In their study they also report an increased body weight of mice in the high-fat diet 
group compared to mice in low-fat diet group, which differs from our study where body weight 
gain of mice in DIO (high-fat diet) did not differ from any other diet, meaning DIO did not have 
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the effect we expected (i.e., the percent body weight gain in DIO statistically higher than AIN-
93G). Another study using the same mouse model and a western style diet in cardiac hypertrophy 
reported increased body weight of mice in the western-style diet compared to the basal chow diet 
group (Mells et al., 2011), which was not the case with our western-style diet (bodyweight gain 
of mice on TWD was equal as the body weight gain of mice on AING-93G diet). 
Even though we were not expecting a similar expression profile of any diet compared to the 
basal diet AING-93G, we were expecting similarities in DIO and TWD (i.e. the same cytokines 
increased or decreased at the same time in both diets). 
To assess the systemic inflammatory response of mice to seven different diets, we 
measured 40 different cytokines in plasma samples. The higher levels of plasma cytokine 
secretion in all vegetable supplemented diets compared to the basal diets (AIN- 93G, DIO TWD) 
also differs from the inverse relationship previous studies have found between vegetable 
consumption and inflammatory markers (Jiang et al., 2014; Navarro et al., 2014; Nettleton et al., 
2006). Nonetheless, all these studies were carried out in humans.   
Moreover, from the analysis of inflammation-related genes in colon samples, none of the 
four colon differentially expressed genes found in our study (Bmp2, Cccl1, Cccl4, Cccl19) were 
altered in the study of Liu et al. (2012) using colon ex vivo culture samples, where obese mice 
had 11 genes up-regulated and 18 genes down-regulated using the same animal and gene array as 
our study. However, they used older mice (6 to 18 weeks old) than our study (4 weeks old) and 
they fed the high fat diet for 12 weeks in one cohort and 17 weeks in the other.  
It is widely accepted that adipose tissue expresses higher levels of pro-inflammatory 
cytokines (TNF- α, IL-1, IL-6) in diet-induced obesity models, and that the macrophages that 
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infiltrate the tissue are responsible for the expression of TNF-α and, IL-6,  and the induction of 
nitric oxide synthase (Rajala & Scherer, 2003); several studies have reproduced these findings 
(K.-A. Kim et al., 2012; Liu et al., 2012). From the review of their methodology and their results, 
we have several discrepancies that may explain the failure of our study to induce obesity and 
inflammation in mice with high-fat diet, and therefore the ability to determine if there is a 
decrease in cytokine expression with vegetable-supplemented diets. Stanton et al. (2011) stated 
that C57BL/6 mice do not gain weight uniformly when fed a high-fat diet, and they decided to 
exclude from the study all mice with less than 7 gram weight gain on day 21 of high-fat diet 
feeding. It is important to mention that in this study cytokine expression was measured in serum 
samples and only IL-6 had a modest increased in the high-fat diet group, while GM-CSF, TNF- 
α, IL-12p70, and IL-1β did not have any increase (levels below the detection limit of the assay). 
Studies that did report elevated levels of TNF- α (K.-A. Kim et al., 2012; Liu et al., 2012), IL-1β, 
IL6 (K.-A. Kim et al., 2012) assessed levels in colon tissue. Concerning the vegetable-
supplemented diets with higher cytokine expression, DC diet had a lowering effect on 
inflammation (with 11 decreased cytokines) compared to DA, which additionally had 7 other 
cytokines increased compared to DIO. The increase in cytokines such as TNF- α, IL6, IL17, and 
IL23, suggest the promotion of inflammation by the vegetable supplemented diets as these 
cytokines are responsible for the activation of the NF-κB transcription factor through the 
canonical pathway. Il-6 can also lead to the activation of STAT3 transcription factor, and induce 
expression of anti-apoptotic genes (Bcl2) and proliferative genes (Cyclin D1, c-Myc), all together 
promoting inflammation and angiogenesis, and inhibiting cellular apoptosis (Terzić et al., 2010). 
We focused our research on the chemo-preventive effect of cruciferous and apiaceous 
vegetables, nonetheless some studies have reported that some compounds (e.g. Indol-3-carbinol) 
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present in these types of vegetables are responsible for the promotion of colon cancer (Pence, 
Buddingh, & Yang, 1986; Temple & El-Khatib, 1987). Furthermore, a trial in healthy adults 
showed a 19% and 20% reduction of IL-6 level by cruciferous- and apiaceous-supplemented 
diets, but no effect of the vegetables on TNF-α or C-reactive protein as markers of inflammation 
(Navarro et al., 2014). All of the above is evidence of the variable effects diet can have on 
inflammation. 
If we compare the plasma cytokine secretion of the ARY006 protein assay with the colon 
mRNA qPCR assay, one can observe that I-309 (Ccl1) was the only gene with increased levels in 
both assays. Nonetheless, protein secretion (I-309) was higher in TA compared to all basal diets 
(AIN-93G, DIO, TWD), but mRNA secretion was higher in TWD, TC, and TA compared to 
AIN-93G and DIO. This can be due to a post-transcriptional modification of the mRNA of the 
elevated cytokines identified with the protein array. In general, differentially expressed mRNAs 
are involved in the recruitment of cells of the immune system (neutrophils, monocytes, tumor-
infiltrating lymphocytes) (Viola, Sarukhan, Bronte, & Molon, 2012), with lower levels on AIN-
93G, DIO, and DC diet.   
One of the main strengths of our study is the formulation of the vegetable supplemented 
diets DC and DA (TC, TA had been previously formulated by Kim et al. (2016)) for many 
reasons: diets were prepared in our lab, all ingredients were purchased from the same company 
and with the same lot number, we used a mix of whole vegetables (not purified phytochemicals) 
in quantities equivalent to a translatable amount of one cup per day for a human, and diets were 
adjusted for macronutrients so even with the supplementation of vegetables all diets had the 
same proportion of macronutrients. 
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The main limitation of our study was that mice on high-fat diets did not achieve obesity, 
which made it difficult to compare our results of the vegetable supplemented diets (DC, DA, TC, 
TA) to basal diets (AIN-93G, DIO, TWD). Another limitation is that we only measured the 
cytokine levels at the end of the feeding period, so we did not have baseline measurements of the 
cytokine levels to compare levels after the feeding trial. We had some difficulties measuring 24-
hour food intake of the powder diets (AIN-93G, TWD), due to spillage of the diet, which we 
resolved somewhat with the use of followers (a special metal lid, with 6 small circular openings); 
but we also believe that the small openings of our food shields and the weight gain of mice over 
time may have cause some skin lesions, therefore we recommend using food cups with bigger 
openings.  Moreover, testing the cytokine expression on plasma samples was a challenge due to 
the limited amount of sample per mouse, and the probability of protein degradation over time 
and per time the sample was thawed.  
Based on the results of our research, we recommend following certain parameters to 
classify a mouse as obese and monitor their weight gain. Selection can be based on the 
percentage of body weight compared to basal diet (30-35% above basal diet), limiting the 
treatment (diet) to the time this parameter is achieved as was describe by Liu et al. (2012). They 
used 17 weeks for one cohort and 12 for the other. Also, have enough replicas of mice per group 
of diet so that once obesity is reached, some can be sampled at this time point and the others can 
separate into groups of diet supplemented with cruciferous or apiaceous vegetables for the time 
we consider that the vegetables would produce an anti-inflammatory and chemo-preventive 
effect. As the adipose tissue plays an important role in pro-inflammatory cytokine secretion, the 
measurement of total body fat could be a useful parameter to compare cytokine levels. If 
possible, measure the cytokine expression in blood, adipose tissue, and colon epithelial cells, as 
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cytokines can have a different expression pattern depending on the tissue type. Also, immuno-
histological testing could be used to confirm macrophage infiltration of tissues, which cells are 
primarily responsible for por-inflammatory cytokine secretion.  
We did not determine that DIO and TWD both induce inflammation and both diets failed 
to induce obesity, nevertheless the cytokine expression profile of these diets was similar. 
Therefore, we did not discard the possibility for a future study which could monitor and achieve 
obesity by these diets and possibly still have a similar cytokine expression.  
The stimulation of higher cytokine secretion by the vegetable-supplemented diets 
compared to basal diets only reassures the complexity and variable effects of vegetables on 
pathways in complex organisms.  
Vegetable-supplemented diets did not have an anti-inflammatory effect but, on the 
contrary, induced the secretion of some pro-inflammatory cytokines. Nonetheless, cruciferous 
vegetables had a smaller response compared to apiaceous vegetables. This contradiction provides 
evidence of the complexity and variability of diet (vegetable) effects on inflammation, and the 
importance of studying their molecular mechanisms as seemingly negative effects on one type of 
pathway should not lead to discarding evidence of its chemo-preventive effects via other 
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